Tower Research Capital LLC (TRC): DRMA position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Tower Research Capital LLC (TRC) on DRMA, newest first. How the timeline and the estimate are built.
Tower Research Capital LLC (TRC) held 3,860 DRMA shares at 2026-06-30 per its 13F-HR filed 2026-08-11.
the latest 13F is the newest step
- period ended2026-06-3013F 3,860 sharesChange vs previous 13F +3,144 shares
<0.01% of the 13F portfolio, value $4,979.
13F-HR 0001533421-26-000008 filed by Tower Research Capital LLC (TRC)
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 716 sharesChange vs previous 13F -1,283 shares
<0.01% of the 13F portfolio, value $866.
13F-HR 0001533421-26-000006 filed by Tower Research Capital LLC (TRC)
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,999 sharesChange vs previous 13F +1,573 shares
<0.01% of the 13F portfolio, value $4,638.
13F-HR 0001533421-26-000004 filed by Tower Research Capital LLC (TRC)
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 426 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $2,139.
13F-HR 0001533421-25-000019 filed by Tower Research Capital LLC (TRC)
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).